Patent: 5,591,605
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,591,605
| Title: | Plant structural gene expression |
| Abstract: | The invention provides genetically modified plant cells having a plant structural gene introduced and expressed therein under the control of a T-DNA promoter. In particular, the invention provides genetically modified plant cells having the phaseolin gene introduced and expressed therein under the control of a T-DNA promoter. Also provided are novel strains of bacteria containing and replicating T-DNA which has been modified to contain an inserted plant structural gene under the control of a T-DNA promoter. Further, the invention provides novel plasmids having the ability to replicate in E. coli and comprising T-DNA which has been modified to contain an inserted plant structural gene under the control of a T-DNA promoter. |
| Inventor(s): | Hall; Timothy C. (College Station, TX), Kemp; John D. (Las Cruces, NM), Slightom; Jerry L. (Kalamazoo, MI), Sutton; Dennis W. (Las Cruces, NM) |
| Assignee: | Mycogen Plant Science, Inc. (San Diego, CA) |
| Application Number: | 08/296,073 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,591,605
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | See Plans and Pricing | 2014-01-07 |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | See Plans and Pricing | 2014-01-07 | |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | See Plans and Pricing | 2014-01-07 | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
